The Application Value of the Central Lymph Node Metastasis Risk Assessment Model in Papillary Thyroid Microcarcinoma of Stage cN0: A Study of 828 Patients
Open Access
- 10 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 843573
Abstract
Background: The aim of this study is to build a risk assessment system for central lymph node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC) of stage cN0 and to explore its application value in clinical practice. Methods: A total of 500 patients with PTMC who underwent thyroid operation from 2013 to 2015 in Ningbo First Hospital were selected as the model group. Independent risk factors related to CLNM in PTMC were analyzed and determined, and a risk assessment system for CLNM was preliminarily established. Furthermore, the clinicopathological data from 328 PTMC patients with the same conditions as the model group from 2016 to 2017 were further collected as the validation group to verify the diagnostic value of the risk assessment system. Results: The risk assessment system was based on the score rating (score ≤ 5 was classified as low risk, 6–8 was classified as medium risk, and ≥9 was classified as high-risk). The area under the receiver operating characteristic curve (ROC) was 0.687 (95% CI: 0.635–0.783). According to the risk assessment system, 328 PTMC patients in the validation group were scored. Among the low-risk group, the moderate-risk group, and the high-group, 96.8%, 58.1%, and 43.2% were the CLNM (-) patients, and 3.1%, 41.9%, and 65.8% were CLNM (+) patients, respectively. The area under ROC was 0.837 (95% CI: 0.778–0.869). Conclusions: The risk assessment system in this study is of diagnostic value and can provide a theoretical foundation for intraoperative decision-making of prophylactic central neck dissection (pCND).Keywords
This publication has 38 references indexed in Scilit:
- Which Hemostatic Device in Thyroid Surgery? A Network Meta-Analysis of Surgical TechnologiesThyroid®, 2013
- Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma: Results of a Study on 1087 Patients and Review of the LiteratureThyroid®, 2012
- Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: International standards guideline statementThe Laryngoscope, 2010
- Differentiated thyroid cancer in a Swedish county – long-term results and quality of lifeActa Oncologica, 2010
- Utility of Contrast-Enhanced Ultrasound for Evaluation of Thyroid NodulesThyroid®, 2010
- Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year periodSurgery, 2008
- The mechanism of recurrent laryngeal nerve injury during thyroid surgery—The application of intraoperative neuromonitoringSurgery, 2008
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Clinically significant prognostic factors for differentiated thyroid carcinomaCancer, 2005
- Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer CommitteeThyroid®, 2004